Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2026)
Zymeworks (ZYME) posted Non-Current Deffered Revenue of $14.61 million for Q1 2026, unchanged from $14.61 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Since Q4 2021, Zymeworks has reported Non-Current Deffered Revenue for 16 quarters.
- Annual Non-Current Deffered Revenue shows a four-year compound annual growth rate of -18.4% (FY2021 to FY2025).
- In prior years, Zymeworks' Non-Current Deffered Revenue was $14.61 million in FY2024 (-55.7%), $32.94 million in FY2023 (+7.7%), $30.59 million in FY2022 (-7.1%) and $32.94 million in FY2021.
- Quarterly Non-Current Deffered Revenue has run from a low of $14.61 million in Q4 2025 to a high of $32.94 million in Q2 2024 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last eight quarters, with an average decline of 26.9%.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q2 2024, with growth of 7.7%; the weakest was Q3 2024, with a decline of 55.7%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $14.61 million (Q4 2025), $14.61 million (Q3 2025) and $14.61 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Zymeworks | 1.89 Bn | 775.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.61 Mn |
| Dec 31, 2025 | 14.61 Mn |
| Sep 30, 2025 | 14.61 Mn |
| Jun 30, 2025 | 14.61 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Sep 30, 2024 | 14.61 Mn |
| Jun 30, 2024 | 32.94 Mn |
| Mar 31, 2024 | 32.94 Mn |
| Dec 31, 2023 | 32.94 Mn |
| Sep 30, 2023 | 32.94 Mn |
| Jun 30, 2023 | 30.59 Mn |
| Mar 31, 2023 | 30.59 Mn |
| Dec 31, 2022 | 30.59 Mn |
| Sep 30, 2022 | 32.94 Mn |
| Dec 31, 2021 | 32.94 Mn |
API Access
Zymeworks Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();